Login / Signup

Premedication with intravenous steroids does not influence the incidence of infusion reactions following infliximab infusions in pediatric inflammatory bowel disease patients-a case-control study.

Elsa A van WassenaerVeronique L MeesterAngelika KindermannBart G P KootMarc A BenningaTim G J de Meij
Published in: European journal of clinical pharmacology (2019)
The incidence of IR was low, and premedication with steroids did not decrease the incidence of IR in this cohort of PIBD patients receiving IFX. Our results indicate that PM with steroids is not indicated in PIBD to prevent IR.
Keyphrases
  • risk factors
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • low dose
  • peritoneal dialysis
  • prognostic factors
  • risk assessment
  • ulcerative colitis
  • patient reported outcomes